HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Keith A Ching Selected Research
Keith A Ching Research Topics
Disease
8
Neoplasms (Cancer)
12/2021 - 01/2012
2
Stomach Neoplasms (Stomach Cancer)
02/2012 - 01/2012
1
Carcinoma (Carcinomatosis)
12/2021
1
Experimental Melanoma
10/2021
1
Residual Neoplasm
12/2020
1
Breast Neoplasms (Breast Cancer)
12/2020
1
Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020
1
Fatigue
01/2020
1
Lymphoma (Lymphomas)
01/2020
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2012
1
Colonic Neoplasms (Colon Cancer)
03/2012
1
Retinoblastoma (Glioblastoma, Retinal)
03/2012
1
Neurodegenerative Diseases (Neurodegenerative Disease)
07/2003
1
Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
07/2003
Drug/Important Bio-Agent (IBA)
4
Biomarkers (Surrogate Marker)
IBA
12/2021 - 03/2012
2
avelumab
IBA
12/2021 - 11/2020
2
Pharmaceutical Preparations
IBA
03/2012 - 01/2012
2
Tyrosine Kinase Inhibitors
IBA
02/2012 - 01/2012
1
Immune Checkpoint Inhibitors
IBA
12/2021
1
Biological Products
IBA
12/2021
1
Interleukin-15 (Interleukin 15)
IBA
10/2021
1
Sunitinib (Sutent)
FDA Link
11/2020
1
Axitinib (AG 013736)
IBA
11/2020
1
Ligands
IBA
11/2020
1
Rituximab (Mabthera)
FDA Link
01/2020
1
utomilumab
IBA
01/2020
1
Insulin-Like Peptides
IBA
12/2013
1
Insulin-Like Growth Factor Binding Protein 5
IBA
12/2013
1
figitumumab
IBA
12/2013
1
Insulin Receptor Substrate Proteins
IBA
12/2013
1
N- (2- (6- (4- cyclobutylamino- 5- trifluoromethylpyrimidine- 2- ylamino)- 1,2,3,4- tetrahydro- 1,4- epiazano- naphthalen- 9- yl)- 2- oxo- ethyl)acetamide
IBA
03/2012
1
Aurora Kinase B
IBA
03/2012
1
Aurora Kinase A
IBA
03/2012
1
Lapatinib (GW572016)
FDA Link
02/2012
1
ErbB Receptors (EGF Receptor)
IBA
02/2012
1
Gefitinib (Iressa)
FDA Link
02/2012
1
Trastuzumab (Herceptin)
FDA Link
02/2012
1
dacomitinib
IBA
02/2012
1
Canertinib (CI 1033)
IBA
02/2012
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
02/2012
1
Afatinib
IBA
02/2012
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2012
1
2- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanol
IBA
01/2012
1
Proto-Oncogene Proteins c-met
IBA
01/2012
1
polyglutamine
IBA
07/2003
1
Ataxin-3
IBA
07/2003
1
Protein Aggregates
IBA
07/2003
1
Ubiquitin
IBA
07/2003
1
Carrier Proteins (Binding Protein)
IBA
07/2003
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
12/2021 - 02/2012
3
Therapeutics
12/2021 - 02/2012
1
Immunotherapy
10/2021
1
Neoadjuvant Therapy
12/2020
1
Precision Medicine
01/2015